Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ROCO kinase activity is controlled by internal GTPase function.

Bertram Weiss1

  • 1Target Research, Bayer Schering Pharma AG13342, Berlin, Germany. bertram.weiss@bayerhealthcare.com

Science Signaling
|June 12, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PAVOOC: designing CRISPR sgRNAs using 3D protein structures and functional domain annotations.

Bioinformatics (Oxford, England)·2018
Same author

Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network.

BMC bioinformatics·2014
Same author

Precompetitive activity to address the biological data needs of drug discovery.

Nature reviews. Drug discovery·2014
Same author

Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines.

Frontiers in oncology·2012
Same author

Phenotype mining for functional genomics and gene discovery.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Phenoclustering: online mining of cross-species phenotypes.

Bioinformatics (Oxford, England)·2010
Same journal

ZNRF3 and RNF43 are active monomeric E3 ubiquitin ligases that self-associate.

Science signaling·2026
Same journal

Allosteric ligands with distinct properties uncover tissue-specific physiological regulation mediated by free fatty acid receptor 2.

Science signaling·2026
Same journal

Diacylglycerol kinase ζ in B lymphocytes supports CD40-mediated immune synapse formation, mTORC1 signaling, and plasma cell fate.

Science signaling·2026
Same journal

The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma.

Science signaling·2026
Same journal

Fattening mother's milk with oxytocin.

Science signaling·2026
Same journal

Virion display reveals MD-1 as an endogenous agonist for the orphan receptor GPRC5B.

Science signaling·2026
See all related articles

Leucine-rich repeat kinase 2 (LRRK2) controls its own kinase activity through its GTPase domain, revealing a novel intrinsic regulation mechanism. This discovery is crucial for understanding Parkinson

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Structural Biology

Background:

  • Small GTPases regulate protein kinases, but some novel multidomain proteins, ROCOs, possess both GTPase and kinase domains.
  • Leucine-rich repeat kinase 2 (LRRK2) is a ROCO protein implicated in Parkinson's disease (PD) due to mutations in its kinase and GTPase domains.
  • Mutations in LRRK2 are linked to increased kinase activity, potentially causing neuronal damage in Parkinson's disease.

Purpose of the Study:

  • To elucidate the intrinsic control mechanism between the GTPase and kinase domains within LRRK2.
  • To understand the structural basis of LRRK2 homodimerization and the impact of PD-associated mutations.

Main Methods:

  • Biochemical assays to determine LRRK2 kinase activity based on guanine nucleotide binding.

Related Experiment Videos

  • Crystal structure determination of the LRRK2 GTPase domain.

    • Main Results:

    • LRRK2 kinase activity is modulated by GTP binding and intrinsically controlled by its adjacent GTPase domain.
    • The crystal structure reveals the ROC GTPase domain mediates LRRK2 homodimerization.
    • The structure provides insights into the molecular effects of Parkinson's disease-associated LRRK2 mutations.

    Conclusions:

    • A novel mechanism of intrinsic control exists between the GTPase and kinase domains in ROCO proteins like LRRK2.
    • Understanding LRRK2's structure and intrinsic regulation is key to deciphering its role in Parkinson's disease.
    • The findings may guide the development of therapeutic strategies targeting LRRK2 in PD.